Lecithinized copper, zinc-superoxide dismutase as a protector against doxorubicin-induced cardiotoxicity in mice

Toxicology and Applied Pharmacology

Volumn 194, Issue 2, 2004, Pages 180-188

  Den Hartog, Gertjan J M ^a   Haenen, Guido R M M ^a   Boven, Epie ^b   Van Der Vijgh, Wim J F ^b   Bast, Aalt ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Antitumor effect; Cardiotoxicity; Doxorubicin; Electrocardiogram; Lecithinized superoxide dismutase; Mouse; PC SOD; Superoxide radical

Indexed keywords

ANTINEOPLASTIC AGENT; CARDIOPROTECTIVE AGENT; COPPER ZINC SUPEROXIDE DISMUTASE; DOXORUBICIN; PROTECTIVE AGENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CARDIOTOXICITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; ELECTROCARDIOGRAM; FEMALE; HEART PROTECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; NUDE MOUSE; OVARY CARCINOMA; XENOGRAFT;

MUS MUSCULUS;

EID: 0345829197     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.taap.2003.09.008     Document Type: Article

References (34)

1. Billingham M.E. The role of endomyocardial biopsy in the diagnosis and treatment of heart disease. Silver M.D. Cardiovascular Pathology. 1983;1205-1224 Churchill Livingstone, New York.
2. Boven E., Schlueper H.M.M., Erkelens C.A.M., Pinedo H.M. Doxorubicin compared with related compounds in a nude mouse model for human ovarian cancer. Eur. J. Cancer. 26:1990;983-986.
3. de Jong J., Guérand W.S., Schoofs P.R., Bast A., van der Vijgh W.J.F. Simple and sensitive quantification of anthracyclines in mouse atrial tissue using high-performance liquid chromatography and fluorescence detection. J. Chromatogr., B: Biomed. Appl. 570:1991;209-216.
4. Eva A., Robbins K.C., Andersen P.R., Srinivasan A., Tronick S.R., Reddy E.P., Ellmore N.W., Galen A.T., Lautenberger J.A., Papas T.S., Westin E.H., Wong Staal F., Gallo R.C., Aaronson S.A. Cellular genes analogous to retroviral onc genes are transcribed in human tumour cells. Nature. 295:1982;116-119.
5. Fujita T., Nishikawa M., Tamaki C., Takakura Y., Hashida M., Sezaki H. Targeted delivery of human recombinant superoxide dismutase by chemical modification with mono- and polysaccharide derivatives. J. Pharmacol. Exp. Ther. 263:1992;971-978.
6. Hamilton T.C., Young R.C., McKoy W.M., Grotzinger K.R., Green J.A., Chu E.W., Whang Peng J., Rogan A.M., Green W.R., Ozols R.F. Characterization of a human ovarian carcinoma cell line (NIH:OVCAR-3) with androgen and estrogen receptors. Cancer Res. 43:1983;5379-5389.
7. Hangaishi M., Nakajima H., Taguchi J.-I., Igarashi R., Hoshino J., Kurokawa K., Kimura S., Nagai R., Ohno M. Lecithinized Cu,Zn-superoxide dismutase limits the infarct size following ischemia-reperfusion injury in rat hearts in vivo. Biochem. Biophys. Res. Commun. 285:2001;1220-1225.
8. Herman E.H., Ferrans V.J. Preclinical animal models of cardiac protection from anthracycline-induced cardiotoxicity. Semin. Oncol. 25:1998;15-21.
9. Hori Y., Hoshino J., Yamazaki C., Sekiguchi T., Miyauchi S., Mizuno S., Horie K. Effect of lecithinized-superoxide dismutase on the rat colitis model induced by dextran sulfate sodium. Jpn. J. Pharmacol. 74:1997;99-103.
10. Igarashi R., Hoshino J., Takenaga M., Kawai S., Morizawa Y., Yasuda A., Otani M., Mizushima Y. Lecithinization of superoxide dismutase potentiates its protective effect against Forssman antiserum-induced elevation in guinea pig airway resistance. J. Pharmacol. Exp. Ther. 262:1992;1214-1219.
11. Igarashi R., Hoshino J., Ochiai A., Morizawa Y., Mizushima Y. Lecithinized superoxide dismutase enhances its pharmacologic potency by increasing its cell membrane affinity. J. Pharmacol. Exp. Ther. 271:1994;1672-1677.
12. Julicher R.H., van der Laarse A., Sterrenberg L., Bloys van Treslong C.H., Bast A., Noordhoek J. The involvement of an oxidative mechanism in the adriamycin induced toxicity in neonatal rat heart cell cultures. Res. Commun. Chem. Pathol. Pharmacol. 47:1985;35-47.
13. Julicher R.H., Sterrenberg L., Bast A., Riksen R.O., Koomen J.M., Noordhoek J. The role of lipid peroxidation in acute doxorubicin-induced cardiotoxicity as studied in rat isolated heart. J. Pharm. Pharmacol. 38:1986;277-282.
14. Kapusta L., Thijssen J.M., Groot-Loonen J., Antonius T., Mulder J., Daniëls O. Tissue doppler imaging in detection of myocardial dysfunction in survivors of childhood cancer treated with anthracyclines. Ultrasound Med. Biol. 26:2000;1099-1108.
15. Keizer H.G., Pinedo H.M., Schuurhuis G.J., Joenje H. Doxorubicin (adriamycin): a critical review of free radical-dependent mechanisms of cytotoxicity. Pharmacol. Ther. 47:1990;219-231.
16. Koning J., Palmer P., Franks C.R., Mulder D.E., Speyer J.L., Green M.D., Hellmann K. Cardioxane-ICRF-187 towards anticancer drug specificity through selective toxicity reduction. Cancer Treat. Rev. 18:1991;1-19.
17. Kwon O.B., Kang J.H. Lipid peroxidation induced by the Cu,Zn-superoxide dismutase and hydrogen peroxide system. Biochem. Mol. Biol. Int. 47:1999;645-653.
18. Mao G.D., Thomas P.D., Lopaschuk G.D., Poznansky M.J. Superoxide dismutase (SOD)-catalase conjugates. Role of hydrogen peroxide and the Fenton reaction in SOD toxicity. J. Biol. Chem. 268:1993;416-420.
19. Olson R.D., Mushlin P.S. Doxorubicin cardiotoxicity: analysis of prevailing hypotheses. FASEB J. 4:1990;3076-3086.
20. Powis G. Anthracycline metabolism and free radical formation. Powis G., Prough R.A. Metabolism and Action of Anti-Cancer Drugs. 1987;211-260 Taylor & Francis, London.
21. Ravid A., Rocker D., Machlenkin A., Rotem C., Hochman A., Kessler Icekson G., Liberman U.A., Koren R. 1,25-Dihydroxyvitamin D3 enhances the susceptibility of breast cancer cells to doxorubicin-induced oxidative damage. Cancer Res. 59:1999;862-867.
22. Sarvazyan N.A., Askari A., Huang W.H. Effects of doxorubicin on cardiomyocytes with reduced level of superoxide dismutase. Life Sci. 57:1995;1003-1010.
23. Singal P.K., Iliskovic N. Doxorubicin-induced cardiomyopathy. N. Engl. J. Med. 339:1998;900-905.
24. Singal P.K., Siveski Iliskovic N., Hill M., Thomas T.P., Li T. Combination therapy with probucol prevents adriamycin-induced cardiomyopathy. J. Mol. Cell. Cardiol. 27:1995;1055-1063.
25. Soule H.D., Vazguez J., Long A., Albert S., Brennan M. A human cell line from a pleural effusion derived from a breast carcinoma. J. Natl. Cancer Inst. 51:1973;1409-1416.
26. Sterrenberg L., Julicher R.H., Goossens P.A., Bast A., Noordhoek J. Non-enzymic lipid peroxidation in microsomes and microsomal phospholipids induced by anthracyclines. Free Radical Res. Commun. 1:1986;369-378.
27. Tamagawa K., Taooka Y., Maeda A., Hiyama K., Ishioka S., Yamakido M. Inhibitory effects of a lecithinized superoxide dismutase on bleomycin-induced pulmonary fibrosis in mice. Am. J. Respir. Crit. Care Med. 161:2000;1279-1284.
28. van Acker S.A.B.E., Kramer K., Grimbergen J.A., van den Berg D.J., van der Vijgh W.J.F., Bast A. Monohydroxyethylrutoside as protector against chronic doxorubicin-induced cardiotoxicity. Br. J. Pharmacol. 115:1995;1260-1264.
29. van Acker S.A.B.E., Kramer K., Voest E., Grimbergen J.A., Zhang J., van der Vijgh W.J.F., Bast A. Doxorubicin-induced cardiotoxicity monitored by ECG in freely moving mice. Cancer Chemother. Pharmacol. 38:1996;95-101.
30. van Acker S.A.B.E., Kramer K., Voest E.E., Grimbergen J.A., Zhang J., van der Vijgh W.J.F., Bast A. Doxorubicin-induced cardiotoxicity monitored by ECG in freely moving mice. A new model to test potential protectors. Cancer Chemother. Pharmacol. 38:1996;95-101.
31. van Acker S.A.B.E., Boven E., Kuiper K., van den Berg D.J., Grimbergen J.A., Kramer K., Bast A., van der Vijgh W.J.F. Monohydroxyethylrutoside, a dose-dependent cardioprotective agent, does not affect the antitumor activity of doxorubicin. Clin. Cancer Res. 3:1997;1747-1754.
32. Venditti P., Balestrieri M., De Leo T., Di Meo S. Free radical involvement in doxorubicin-induced electrophysiological alterations in rat papillary muscle fibres. Cardiovasc. Res. 38:1998;695-702.
33. Villani F., Monti E., Piccinini F., Favalli L., Lanza E., Rozza Dionigi A., Poggi P. Relationship between doxorubicin-induced ECG changes and myocardial alterations in rats. Tumori. 72:1986;323-329.
34. Yamazaki C., Hoshino J., Hori Y., Sekiguchi T., Miyauchi S., Mizuno S., Horie K. Effect of lecithinized-superoxide dismutase on the interstitial pneumonia model induced by bleomycin in mice. Jpn. J. Pharmacol. 75:1997;97-100.